新冠疫情噬虐全球，重创人类健康和社会发展，更给科技界和医学界提出重大挑战，呼吁各国研究人员携手，务实推进科研合作。为此，“一带一路”国际科学组织联盟(ANSO)、中国科学院上海巴斯德研究所和ANSO传染病联盟（ANSO-AID）发起并主办“新冠肺炎学术研讨会”(视频)，就病毒学、流行病学、免疫学、抗体疫苗和新药研发等主题深入交流，并广泛探讨合作机制。

会议时间为2022年1月26日（北京时间14:00-19:30），

请登录Bilibili （http://live.bilibili.com/22476145）、Zoom会议室（https://zoom.us/j/4285445842）免费参会，并就感兴趣的话题和嘉宾进行直接交流。

ANSO-AID由中科院上海巴斯德所牵头成立的，秉承平等、共建、共享原则，旨在建立全球传染病防控科技合作网络，推动传染病相关基础研究、药物疫苗研发和临床研究，扩大ANSO在推动构建人类卫生健康共同体中的影响力和贡献度。

欢迎关注并参会，谢谢！

The global catastrophe COVID-19 has led to an “all-hands-on-deck” collaborative effort across the scientific community, and called on researchers from all over the world to join hands and pragmatically promote scientific collaboration.

This free visual Symposium “ANSO-AID Research Progress on COVID-19 Pandemic” is jointly organized by the Alliance of International Science Organizations (ANSO) and to be hosted by the Institut Pasteur of Shanghai, Chinese Academy of Sciences (IPS) and ANSO Alliance of Infectious Diseases (ANSO-AID) on Wednesday January 26th, 2022 (14:00-19:30, Beijing Time). 

We aim to facilitate such a scientific dialogue on COVID-19, focus on topics including virology, epidemiology, immunology, antibody vaccines and new drug countermeasures etc., and to widely explore the collaboration mechanisms. 

Please click the  Bilibili link （http://live.bilibili.com/22476145）and Zoom meeting（https://zoom.us/j/4285445842）to attend the meeting.

ANSO-AID was created and led by Institut Pasteur of Shanghai, the Chinese Academy of Sciences. The purpose of ANSO-AID is: adhere to the principles of "Extensive Consultation, Joint Contribution and Shared Benefits", establish a global scientific and technological cooperation network for infectious disease prevention and control, promote basic research, drug and vaccine research and development and clinical research related to infectious diseases and expand the influence and contribution of ANSO in promoting the construction of a human health community.

Thank you for your attention.